Excellent quality and fast dispatch
Products arrived well-packaged with COA documentation included. Really appreciate the clear research-only labelling — exactly what I needed for my lab work.
James R.
Sydney, AU
BPC-157 + TB-500 + GHK-Cu Stack
GLOW Blend Australia
Everything researchers need to know about GLOW Blend — mechanism, published dosing protocols, side effect profiles, reconstitution, and how to source third-party tested GLOW Blend in Australia.
Quick facts
- Also known as: BPC-157 + TB-500 + GHK-Cu Recovery Stack
- Form: Lyophilised powder (>99% purity)
- Variants: 70 mg total
- 🇦🇺 3–5 business days
March 2025
Best local supplier I've found
Ordered three times now. HPLC verification results have been consistent each time. The pathway browsing structure makes it much easier to compare compounds.
Sarah K.
Melbourne, AU
Fast shipping, great documentation
Same-day dispatch on my last two orders. The batch COA was easy to locate and the product information pages are genuinely useful for research planning.
Michael T.
Brisbane, AU
Representative of verified researcher feedback.
Overview
What Is GLOW Blend?
The GLOW Blend combines three of the most researched recovery peptides — BPC-157 (10 mg), TB-500 (10 mg), and GHK-Cu (50 mg) — in a single vial. This blend targets multiple tissue repair pathways simultaneously: BPC-157 for cytoprotection, TB-500 for cell migration, and GHK-Cu for collagen and gene expression modulation.
Also known as BPC-157 + TB-500 + GHK-Cu Recovery Stack, GLOW Blend is supplied as a lyophilised research peptide for laboratory use only. Each component targets complementary mechanisms: BPC-157 activates VEGF/EGF and the FAK-paxillin pathway, TB-500 promotes actin polymerisation and cell motility, and GHK-Cu modulates 4,000+ genes involved in tissue remodelling. The combination aims to provide comprehensive coverage of wound healing, anti-inflammatory, and regenerative research pathways.
Mechanism
How GLOW Blend Works — Research Mechanism
Each component targets complementary mechanisms: BPC-157 activates VEGF/EGF and the FAK-paxillin pathway, TB-500 promotes actin polymerisation and cell motility, and GHK-Cu modulates 4,000+ genes involved in tissue remodelling. The combination aims to provide comprehensive coverage of wound healing, anti-inflammatory, and regenerative research pathways.
- BPC-157 (10 mg): cytoprotection via VEGF/EGF and FAK-paxillin pathway
- TB-500 (10 mg): actin polymerisation and cell migration
- GHK-Cu (50 mg): collagen synthesis and 4,000+ gene modulation
- Triple-pathway tissue repair coverage in single vial
- Complementary mechanisms for comprehensive regenerative research
Research reference
GLOW Blend Dosage — Published Research Protocols
The following reference points are drawn from published research literature. These figures are provided for research reference only and do not constitute dosing recommendations. GLOW Blend is sold strictly for laboratory research use.
| Protocol tier | Published research detail |
|---|---|
| Blend composition | BPC-157 10 mg + TB-500 10 mg + GHK-Cu 50 mg per vial (70 mg total) |
| Research context | Used in protocols studying multi-pathway tissue repair and remodelling |
| Reconstitution | Reconstitute entire vial with appropriate bacteriostatic water volume for your protocol |
Research use only: FOR LABORATORY RESEARCH USE ONLY. Not for human consumption, injection, or therapeutic use. All products are sold strictly as research chemicals. By purchasing, you confirm you are 18+ and agree to use products solely for legitimate research purposes.
Safety research
GLOW Blend Side Effects — Research Findings
Side effect profiles documented in published GLOW Blend research depend on dose, route of administration, and model system. The following are commonly reported findings from research literature — not from personal use contexts.
- Injection site erythema or discomfort in subcutaneous administration studies
- Transient local inflammation reported in some tissue repair models
- Generally well-tolerated in published preclinical research at standard doses
- No significant systemic adverse events consistently reported across literature
Handling
Reconstituting GLOW Blend
GLOW Blend is supplied as a lyophilised powder and must be reconstituted before use in laboratory protocols. Use bacteriostatic water (0.9% benzyl alcohol) for multi-dose vials. Inject diluent slowly down the inside wall of the vial — do not shake vigorously.
Bacteriostatic water is available from EvoPeak. Store reconstituted peptide at 2–8°C and lyophilised powder at −20°C.
Shop bacteriostatic waterAustralia
How to Get GLOW Blend in Australia
Researchers in Australia can source GLOW Blend through EvoPeak — a local supplier offering third-party tested research compounds with batch-specific COA documentation and domestic shipping.
- 1
Browse GLOW Blend variants (70 mg total) on the EvoPeak product page
- 2
Review the certificate of analysis (COA) for HPLC purity and mass spectrometry identity verification
- 3
Select your vial size and add to cart — prices include GST with same-day Australian dispatch
- 4
Receive your order with batch-specific quality documentation for laboratory traceability
Quality Standard
Research compounds need evidence, not guesswork.
Every shopping path leads back to the same core standard: research-use positioning, third-party quality signals, transparent documentation, and careful handling guidance.
HPLC/MS verified
Purity and identity checks support confident compound selection for controlled research.
Endotoxin screened
Quality review extends beyond purity so researchers can evaluate handling risk.
Batch documentation
COA-first product pages keep quality signals close to every purchase decision.
Australia shipped
Local fulfilment keeps delivery predictable for Australian research customers.
FAQ
GLOW Blend — Common Questions
What is GLOW Blend?
Triple-peptide recovery blend for comprehensive tissue repair research. The GLOW Blend combines three of the most researched recovery peptides — BPC-157 (10 mg), TB-500 (10 mg), and GHK-Cu (50 mg) — in a single vial. This blend targets multiple tissue repair pathways simu… It is supplied for laboratory research use only.
What is the GLOW Blend dosage used in research?
Published research uses varying doses depending on the model and endpoint. EvoPeak supplies 70 mg total vials. All dosage information is for research reference only and does not constitute recommendations.
What are the side effects of GLOW Blend?
Side effect profiles in published research depend on dose, route, and model system. Consult primary literature for compound-specific findings. All information is drawn from research contexts, not personal use.
Can I buy GLOW Blend in Australia?
Yes. EvoPeak supplies research-grade GLOW Blend to Australian researchers with HPLC/MS verification, batch-specific COA documentation, and domestic shipping. Products are for laboratory research use only.
How do I get GLOW Blend in Australia?
Order from the EvoPeak shop page, select your vial size, review the COA, and checkout with local Australian fulfilment.
How do I reconstitute GLOW Blend?
GLOW Blend is supplied as lyophilised powder. Reconstitute with bacteriostatic water, inject diluent slowly down the vial wall without shaking, and store at 2–8°C once reconstituted. Bacteriostatic water is available from EvoPeak.
What purity standard does EvoPeak GLOW Blend meet?
Every batch undergoes HPLC purity analysis (targeting >99%), mass spectrometry identity verification, and endotoxin screening. Batch-specific COAs are available on the product page.
Is glow blend peptide the same as BPC-157 + TB-500 + GHK-Cu Recovery Stack?
GLOW Blend is also known as BPC-157 + TB-500 + GHK-Cu Recovery Stack. Both refer to the same research compound supplied by EvoPeak.
Related compounds
Explore related research peptides
Ready to order GLOW Blend?
Third-party HPLC/MS tested with batch-specific COA documentation. Shipped from Australia for laboratory research use only.